Suppr超能文献

针对产OXA-23碳青霉烯酶的广泛耐药鲍曼不动杆菌,黏菌素联合用药的体外协同作用

In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase.

作者信息

Wei Wenjuan, Yang Haifei, Liu Yanyan, Ye Ying, Li Jiabin

机构信息

a Department of Infectious Diseases , the First Affiliated Hospital of Anhui Medical University , Hefei , China.

b Institute of Bacterium Resistance , Anhui Medical University , Hefei , China.

出版信息

J Chemother. 2016 Jun;28(3):159-63. doi: 10.1179/1973947815Y.0000000030. Epub 2016 Apr 22.

Abstract

Fifty extensively drug-resistant Acinetobacter baumannii (XDRAB) were isolated from patients. The chequerboard microdilution method was used to determine the in vitro activities of five colistin (COL)-based combinations including COL+fosfomycin (FOS), COL+rifampicin (RIF), COL+imipenem (IMP), COL+sulbactam (SUP) and COL+levofloxacin (LVX). The synergistic activity was evaluated by the fractional inhibitory concentration index (FICI). According to our results, the combination of COL was synergistic with FOS, RIF, IMP, SUP and LVX with the ratios of 50, 72, 88, 92 and 64%, respectively. When combined with COL, the other five agents showed increased antimicrobial activities. In addition, two of the combinations, COL+RIF and COL+IMP, were more active than the combinations of COL+FOS, COL+SUP and COL+LVX. More importantly, these combination regimens could exert synergistic effects at the sub-minimum inhibitory concentration (MIC) levels against XDRAB strains.

摘要

从患者中分离出50株广泛耐药鲍曼不动杆菌(XDRAB)。采用棋盘微量稀释法测定了5种以黏菌素(COL)为基础的联合用药方案的体外活性,包括COL+磷霉素(FOS)、COL+利福平(RIF)、COL+亚胺培南(IMP)、COL+舒巴坦(SUP)和COL+左氧氟沙星(LVX)。通过分数抑菌浓度指数(FICI)评估协同活性。根据我们的结果,COL与FOS、RIF、IMP、SUP和LVX联合用药时分别有50%、72%、88%、92%和64%的比例表现出协同作用。与COL联合使用时,其他5种药物的抗菌活性增强。此外,COL+RIF和COL+IMP这两种联合用药方案比COL+FOS、COL+SUP和COL+LVX联合用药方案更具活性。更重要的是,这些联合用药方案在低于最低抑菌浓度(MIC)水平时对XDRAB菌株可发挥协同作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验